Fluorescence In Situ Hybridization, Topoisomerase Ii Alpha, Gene Amplification And Deletio — Dako Denmark A/S (PMA P050045)
Fluorescence In Situ Hybridization, Topoisomerase Ii Alpha, Gene Amplification And Deletio — Dako Denmark A/S (PMA P050045) is one of 9,000 device clearances in the DeviceClear dataset. Key details — Device name: Fluorescence In Situ Hybridization, Topoisomerase Ii Alpha, Gene Amplification And Deletio; Applicant: Dako
| Device name | Fluorescence In Situ Hybridization, Topoisomerase Ii Alpha, Gene Amplification And Deletio |
|---|---|
| Applicant | Dako Denmark A/S |
| Clearance track | PMA |
| Submission number | P050045 |
| Decision | OK30 |
| Decision date | 2011-11-10 |
| Date received | 2011-10-06 |
| Product code | NXG |
| Device class | 3 |
| Medical specialty | Unknown |
| Applicant location | US |
| Source | openFDA device |
🔍 Search all device clearances →
$1999/mo
Try DeviceClear →